Literature DB >> 2317110

Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.

M J Ahern1, P J Roberts-Thomson, J Bradley, C Story, P Seshadri.   

Abstract

Phenotypic and genotypic characteristics of the peripheral blood mononuclear cells in nine patients with Felty's syndrome have been examined. One patient had an increased number and percentage of peripheral blood mononuclear cells with the phenotype CD3+ Leu-7+ CD16+ and showed a clonal rearrangement of the T cell receptor B chain gene. The remaining eight patients all showed a germline configuration of the T cell receptor B chain gene. In two patients an increased proportion of CD3+ Leu-7+ CD16- peripheral blood mononuclear cells (45 (SD 11)% of peripheral blood mononuclear cells) were found, while the remaining six patients had proportions of CD3+ Leu-7+ cells similar to those of patients with uncomplicated rheumatoid arthritis. These data confirm that patients with Felty's syndrome are heterogeneous, with at least three different peripheral blood mononuclear cell phenotypic subsets. One subset is characterised by a clonal expansion of an unusual lymphocyte subpopulation, another by polyclonal expansion, and the third subset has the same proportions of peripheral blood mononuclear cells as patients with uncomplicated rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317110      PMCID: PMC1003987          DOI: 10.1136/ard.49.2.103

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome.

Authors:  B Freimark; L Lanier; J Phillips; T Quertermous; R Fox
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

Review 4.  Lymphocytosis of large granular lymphocytes.

Authors:  W C Chan; E F Winton; T A Waldmann
Journal:  Arch Intern Med       Date:  1986-06

5.  Clonal proliferation of large granular lymphocytes in rheumatoid arthritis.

Authors:  T P Loughran; G Starkebaum; P Kidd; P Neiman
Journal:  Arthritis Rheum       Date:  1988-01

6.  Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

Authors:  Y Yoshikai; D Anatoniou; S P Clark; Y Yanagi; R Sangster; P Van den Elsen; C Terhorst; T W Mak
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

7.  Unusual T cell proliferations and neutropenia in rheumatoid arthritis: comparison with classical Felty's syndrome.

Authors:  D C Linch; A C Newland; A L Turnbull; L J Knott; A MacWhannel; P Beverley
Journal:  Scand J Haematol       Date:  1984-10

8.  Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders.

Authors:  A C Aisenberg; T G Krontiris; T W Mak; B M Wilkes
Journal:  N Engl J Med       Date:  1985-08-29       Impact factor: 91.245

9.  Large granular lymphocyte leukemia. Report of 38 cases and review of the literature.

Authors:  T P Loughran; G Starkebaum
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

10.  Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome.

Authors:  G Starkebaum; J W Singer; W P Arend
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more
  2 in total

Review 1.  Acquired pure red cell aplasia: updated review of treatment.

Authors:  Kenichi Sawada; Naohito Fujishima; Makoto Hirokawa
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998

2.  Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.

Authors:  Bogdan Dumitriu; Sawa Ito; Xingmin Feng; Nicole Stephens; Muharrem Yunce; Sachiko Kajigaya; Joseph J Melenhorst; Olga Rios; Priscila Scheinberg; Fariba Chinian; Keyvan Keyvanfar; Minoo Battiwalla; Colin O Wu; Irina Maric; Liqiang Xi; Mark Raffeld; Pawel Muranski; Danielle M Townsley; Neal S Young; Austin J Barrett; Phillip Scheinberg
Journal:  Lancet Haematol       Date:  2015-12-17       Impact factor: 18.959

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.